Healthcare Leader: Bivalent Vaccine Offers Best Protection Against Serious Illness, Plus: Opioid Stewardship and more

May 31, 2023

Bivalent Vaccine Vital in Preventing Serious Illness

COVID-19 remains the fourth leading cause of death in the US, with a daily average of 250 deaths, mostly among immunocompromised and older individuals. You can help protect your patients, residents and community by offering the bivalent COVID-19 vaccines, which are safe and effective at protecting people from getting seriously ill, being hospitalized, and dying. Learn more.

Weekly COVID-19 Snapshot

Check Your Community's Stats

Opioid Stewardship Affinity Group for Hospital Providers June 12

IPRO's Opioid Stewardship Affinity Group highlights best practices, resources and successful strategies to initiate or expand a hospital Opioid Stewardship program. Attendees can bring their questions to subject matter experts Alex LaPietra, DO, FACEP, FAAEM, System Director, Addiction Medicine, Emergency Service Line, and Michael Litterer, CHES, CPS, FHELA, Vice President, RWJ Barnabas Health Institute for Prevention and Recovery. Topics will include Hospital-Based Peer Recovery Programs and the use of EPIC; ED provider-focused quality measures; and the importance of multi-sector, multi-discipline advisory committees.

When: June 12, 2023, 11 am - 12 pm EST

Download these resources to support your work:

Each week we offer an array of educational opportunities. Please visit our calendar to learn more and register for upcoming events. For educational modules you can complete at your own convenience and your own pace, visit IPRO Learn, our new online learning platform..

Visit our website
Email us
Call us toll-free at 888-502-0566

Visit Our Resource Library

Join Our Network

www.qi.ipro.org

The IPRO QIN-QIO works to ensure high-quality, safe health care in New England, New York, New Jersey, Ohio, Delaware, Maryland, and the District of Columbia.

This material was prepared by the IPRO QIN-QIO, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this document do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. 12SOW-IPRO-QIN-T1-AA-21-435